CCMB team identifies genes that spur nerve repair
You don’t have any Active Subscription.
Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription
Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, have identified two genes that can restore damaged nerve cells’ ability to regenerate, raising the possibility of new gene-based treatments for paralysis caused by spinal cord injuries.
The study, led by Ishwariya Venkatesh, found that activating two developmental genes, NR2F1 and NR2F6, enabled severed nerve fibres to regrow across completely injured spinal cords in mice, leading to measurable improvements in movement.
The spinal cord transmits signals from the brain to the rest of the body, enabling movement and sensation. Damage to it can cause paralysis because nerve cells in adult mammals generally lose their ability to regenerate. Despite decades of research, there is no treatment that can restore the lost neural connections.
The researchers sought to understand why young neurons can grow and regenerate while adult neurons cannot. Their investigation focused on proteins that activate growth-related genes during development but become less active as the brain matures. The team discovered that the genes NR2F1 and NR2F6, which had not previously been linked to nerve regeneration, decline by 70-80% in adult brains.
Restoring either gene in adult mice prompted damaged nerve fibres to regenerate across the injury site and extend beyond it. Untreated animals, by contrast, showed little or no regrowth. The treated mice also showed improved mobility, including better hind-limb movement and grip strength. Recovery became evident about five weeks after the injury and continued thereafter.
The two genes, however, triggered regeneration through different mechanisms. NR2F1 activated genes involved in remodelling DNA and rebuilding cellular structures needed for growth. NR2F6, meanwhile, suppressed several routine cellular activities, allowing neurons to redirect resources towards repairing damaged nerve fibres.
The team also found that NR2F6 reorganises the three-dimensional structure of DNA in injured neurons, bringing growth-related genes closer to the regulatory elements that control their activity. Researchers said this was the first evidence linking large-scale genome reorganisation to nerve regeneration in the brain or spinal cord.
Published in The EMBO Journal, the study is still at the preclinical stage. The genes were delivered before the injury in mice, and the recovery was partial. The findings, however, offer a potential framework for developing gene-based therapies to repair spinal cord damage, said a press release.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.